Oncopharmpod
Keynote 811 Update
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:12:59
- Mas informaciones
Informações:
Sinopsis
The updated Keynote 811 OS results convert an accelerated approval for pembrolizumab to a regular approval, albeit restricted by PD-L1 CPS status of 1 or higher.
